News for Viatris Inc. (VTRSV)

We recently published an article titled Why These 15 Large-Cap Stocks Are Plunging So Far In 2025. In this article, we are going to take a look at where Viatris Inc.

Stocks Analysis by Investing.com (Alessandro Bergonzi) covering: S&P 500, Pfizer Inc, Edison International, Viatris Inc. Read Investing.com (Alessandro Bergonzi)'s latest article on Investing.com

PR NewswireNEW YORK, March 3, 2025 NEW YORK, March 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Viatris Inc. ("V

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going to take a look at where Viatris Inc.

The headline numbers for Viatris (VTRS) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

We recently compiled a list of the 10 Stocks Drop by Double Digits Mostly Due to Disappointing Earnings. In this article, we are going to take a look at where Viatris Inc.

Total Revenue: $14.7 billion for 2024, up 2% year over year.Adjusted EBITDA: Approximately $4.7 billion for 2024.Adjusted EPS: $2.65 per share for 2024.Free Ca

Feb 27, 2025 / 01:30PM GMTOperator Good morning, everyone, and welcome to the Viatris Q4 and full year 2024 earnings call. (Operator Instructions) Please also n

**media[552929]**

The S&P 500 fell 1.6% on Thursday, Feb. 27, as Nvidia led semiconductor and AI stocks lower and investors digested President Trump's latest announcement on tariffs.

Viatris Inc. (NASDAQ:VTRS) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ETCompany ParticipantsBill Szablewski - Head of Capital MarketsScott...

Viatris Inc. missed sales/EPS estimates with 2025 guidance showing challenges like a $385M EBITDA hit. Learn why experts suggest avoiding VTRS stock.

The following slide deck was published by Viatris Inc.

Quarterly Revenue: $3.52 billion, missing the estimated $3.61 billion.Quarterly EPS: Adjusted EPS of $0.54, above the estimated $0.28.Annual Revenue: $14.7 bil

Summary On February 27, 2025, Viatris Inc (VTRS) announced its 2025 dividend policy, which includes a total annual dividend of 48 cents per share. The Board of

PR NewswirePITTSBURGH, Feb. 27, 2025 PITTSBURGH, Feb. 27, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that on February 24, 2025, its B

PR NewswireDUBLIN, Feb. 26, 2025 YUPELRI® (revefenacin) US net sales, recognized by Viatris, reached an all-time high of $66.7 million in Q4 2024 and $238

**media[550416]**

Long-established in the Drug Manufacturers industry, Viatris Inc (VTRS) has enjoyed a stellar reputation. It has recently witnessed a daily gain of 0.22%, juxta